Literature DB >> 30887153

The application of ApcMin/+ mouse model in colorectal tumor researches.

Junze Ren1, Hua Sui2, Fanfu Fang1, Qi Li3, Bai Li4.   

Abstract

PURPOSE: ApcMin/+ mouse is an excellent animal model bearing multiple intestinal neoplasia, used to simulate human familial adenomatous polyposis and colorectal tumors. The key point of this model is the mutation of Apc gene, which is a significant tumor-suppressor gene in the Wnt signaling pathway. There are also some other possible mechanisms responsible for the development of colorectal tumors in the ApcMin/+ mouse model, such as tumor-associated signaling pathways activation, the changes of tumor-related genes, and the involvement of some related proteins or molecules.
METHODS: The relevant literatures about ApcMin/+ mouse model from PUBMED databases are reviewed in this study.
RESULTS: In recent years, increasing studies have focused on the application of ApcMin/+ mouse model in colorectal tumor, trying to find effective therapeutic targets for further use.
CONCLUSION: This article will give a brief review on the related molecular mechanisms of the ApcMin/+ mouse model and its application in colorectal tumor researches.

Entities:  

Keywords:  Animal models; Apc Min/+; Application; Colorectal tumor; Molecular targets

Mesh:

Substances:

Year:  2019        PMID: 30887153     DOI: 10.1007/s00432-019-02883-6

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  10 in total

1.  The effects of aerobic exercise on the intestinal tumors and flora of the ApcMin/+ mouse.

Authors:  J Ren; B Guo; H Sui; J Chen; L Zhang; C Lv; B Li
Journal:  Clin Transl Oncol       Date:  2021-08-26       Impact factor: 3.405

2.  Mutational inactivation of Apc in the intestinal epithelia compromises cellular organisation.

Authors:  Helena Rannikmae; Samantha Peel; Simon Barry; Takao Senda; Marc de la Roche
Journal:  J Cell Sci       Date:  2021-01-27       Impact factor: 5.285

3.  A molecular subtype of colorectal cancers initiates independently of epidermal growth factor receptor and has an accelerated growth rate mediated by IL10-dependent anergy.

Authors:  Carolina Mantilla-Rojas; Ming Yu; Erica S Rinella; Rachel M Lynch; Amie Perry; Jorge Jaimes-Alvarado; Kathryn R Anderson; Estefania Barba; Evann J Bourgeois; Kranti Konganti; David W Threadgill
Journal:  Oncogene       Date:  2021-03-25       Impact factor: 8.756

4.  Transition state analogue of MTAP extends lifespan of APCMin/+ mice.

Authors:  Ross S Firestone; Mu Feng; Indranil Basu; Karina Peregrina; Leonard H Augenlicht; Vern L Schramm
Journal:  Sci Rep       Date:  2021-04-23       Impact factor: 4.379

Review 5.  Organoid: Next-Generation Modeling of Cancer Research and Drug Development.

Authors:  Jungang Liu; Xiaoliang Huang; Lihaoyun Huang; Jinlian Huang; Dingyu Liang; Lixian Liao; Yuqing Deng; Lihua Zhang; Beibei Zhang; Weizhong Tang
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 6.244

6.  RNA-binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA.

Authors:  Rong Mu Xia; Tao Liu; Wen Gang Li; Xiu Qin Xu
Journal:  Clin Transl Med       Date:  2021-10

7.  Sodium salicylate and 5-aminosalicylic acid synergistically inhibit the growth of human colon cancer cells and mouse intestinal polyp-derived cells.

Authors:  Hideki Takakura; Mano Horinaka; Ayaka Imai; Yuichi Aono; Toshimasa Nakao; Shingo Miyamoto; Yosuke Iizumi; Motoki Watanabe; Takumi Narita; Hideki Ishikawa; Michihiro Mutoh; Toshiyuki Sakai
Journal:  J Clin Biochem Nutr       Date:  2021-12-18       Impact factor: 3.114

8.  Study of the colonic epithelial-mesenchymal dialogue through establishment of two activated or not mesenchymal cell lines: Activated and resting ones differentially modulate colonocytes in co-culture.

Authors:  Pascale Plaisancié; Charline Buisson; Edwin Fouché; Pierre Martin; Céline Noirot; Claire Maslo; Jacques Dupuy; Françoise Guéraud; Fabrice Pierre
Journal:  PLoS One       Date:  2022-08-30       Impact factor: 3.752

9.  Baoyuan Jiedu decoction alleviating cancer cachexia-Induced muscle atrophy by regulating muscle mitochondrial function in Apc Min/+ mice.

Authors:  Beiying Zhang; Qianyu Bi; Shengqi Huang; Siyuan Lv; Xin Zong; Mengran Wang; Xuming Ji
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

10.  YYFZBJS ameliorates colorectal cancer progression in ApcMin/+ mice by remodeling gut microbiota and inhibiting regulatory T-cell generation.

Authors:  Hua Sui; Lu Zhang; Kaijuan Gu; Ni Chai; Qing Ji; Lihong Zhou; Yan Wang; Junze Ren; Limei Yang; Bimeng Zhang; Jing Hu; Qi Li
Journal:  Cell Commun Signal       Date:  2020-07-16       Impact factor: 5.712

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.